MARKETS / NASDAQ / ADUS
NASDAQ · SERVICES-HOME HEALTH CARE SERVICES · LARGE CAP

Addus HomeCare Corp. ADUS

17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$1.4B
▲ 23.2% vs FY2024
EPS · FY25
$5.22
Dividend / sh · FY25
Payout · FY25
ROE · FY25
9.3%
Net margin · FY25
6.7%
Dividend coverage
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 1.4B
Revenue, FY2025 · full 17-year series below
Revenue Net income
0.40.81.21.61.40.12009201220152018202120242025
0.40.81.21.61.40.12016201920222025

7 cents of every revenue dollar became profit this year.

Per share
USD 5.22
Diluted EPS, FY2025
EPS
2465.222009201220152018202120242025
2465.222016201920222025

The company pays no cash dividend.

Profitability
9.3%
Return on equity, FY2025
ROE
51015209.3%2009201220152018202120242025
51015209.3%2016201920222025
Operating margin9.7%
Net margin6.7%
Return on assets6.7%

Each USD of equity produced 9 cents of profit this year.

Returned to shareholders
returned in FY2025 · dividends + net buybacks
Dividends paid
Net buybacks
Share of profit
Consecutive raises

Growth
+13.2% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+14.4%
+13.2%
+15.5%
+12.9%
Net income
+27.7%
+23.7%
+23.5%
+20.3%
EPS, diluted
+22.5%
+20.2%
+17.5%
+15.9%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.02B
Shares outstanding, FY2025
0.010.022009201220152018202120242025
0.010.022016201920222025
Change, 5 years+17.0%
Change, 10 years+66.7%

The share count grew 17% in five years — the same company, cut into more, smaller slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 1.4B
total assets, end of FY2025
Total assetsUSD 1.4B
EquityUSD 1.1B
Gross debtUSD 121.0M
Current ratio1.80×

Equity funds 76% of total assets.

History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
1.4
1.2
1.1
1.0
0.9
0.8
0.6
0.5
0.4
0.4
0.3
0.3
0.3
0.2
0.2
0.2
0.3
Operating income $B
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
EBITDA $B
0.2
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
0.0
0.0
EPS, diluted $
5.22
4.23
3.83
2.84
2.81
2.08
1.77
1.33
1.03
1.07
1.04
1.10
1.73
0.71
−0.18
0.57
−0.66
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
9.3
8.8
9.3
7.6
8.3
6.7
6.8
7.5
7.4
8.2
8.7
10.2
18.4
8.4
−2.3
6.8
·
Shares out B
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
·

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
66 of 66
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed